The N-terminal portion of TFE3 is being replaced by ASPSCR1 (ASPL) sequences, while retaining its DNA-binding domain, and is implicated in transcriptional deregulation and pathogenesis of this type of sarcoma [41]. The gene discussed is ASPSCR1; the disease is sarcoma.